Khoa Anh Tran

Khoa Anh Tran

Auto-generated profile, based on publicly available information

Khoa Anh Tran

Cancer Program, QIMR Berghofer Medical Research Institute, 300 Herston Road, Brisbane, Australia.

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
KTKhoa A. Tran
Khoa A. Tran
VAVenkateswar Addala
Venkateswar Addala
RJRebecca L. Johnston
Rebecca L. Johnston
DLDavid Lovell
David Lovell
ABAndrew Bradley
Andrew Bradley
Nic WaddellNic Waddell
Nic Waddell
Cells within the tumour microenvironment (TME) can impact tumour development and influence treatment response. Computational approaches have been developed to deconvolve the TME from bulk RNA-seq. Using scRNA-seq profiling from breast tumours we simulate thousands of bulk mixtures, representing tumour purities and cell lineages, to compare the performance of nine TME deconvolution methods (BayesPrism, Scaden, CIBERSORTx, MuSiC, DWLS, hspe, CPM, Bisque, and EPIC).Some methods are more robust in deconvolving mixtures with high tumour purity levels. Most methods tend to mis-predict normal epithelial for cancer epithelial as tumour purity increases, a finding that is validated in two independent datasets. The breast cancer molecular subtype influences this mis-prediction. BayesPrism and DWLS have the lowest combined numbers of false positives and false negatives, and have the best performance when deconvolving granular immune lineages. Our findings highlight the need for more single-cell characterisation of rarer cell types, and suggest that tumour cell compositions should be considered when deconvolving the TME.

9 December 2021
Verified
Book Chapter
Closed access
PDF file
DLDavid Lovell
David Lovell
BMBridget McCarron
Bridget McCarron
BLBrendan Langfield
Brendan Langfield
KTKhoa Tran
Khoa Tran
ABAndrew P. Bradley
Andrew P. Bradley

25 March 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
KTKhoa A. Tran
Khoa A. Tran
VAVenkateswar Addala
Venkateswar Addala
LKLambros T. Koufariotis
Lambros T. Koufariotis
JZJia Zhang
Jia Zhang
SWScott Wood
Scott Wood
Nic WaddellNic Waddell
Nic Waddell
Background: Immunotherapy has improved patient survival for multiple cancer types, including melanoma. While a variety of molecular features have been linked to response to immune checkpoint inhibitors (ICI) treatment, clinically established biomarkers, such as tumour mutation burden (TMB) and PD-L1 expression, have shown limitations in accurately categorising responders versus non-responders. Due to the complex nature of ICI response, which includes cancer intrinsic and extrinsic features within the tumour microenvironment (TME), using a single biomarker to predict response is insufficient, necessitating the need to identify accurate clinical and multi-omic molecular predictors. Methods: We integrate clinical, DNA and RNA sequencing data from four datasets, comprising 138 melanoma patients treated with ICI, to develop machine learning models for predicting ICI response. The performance of each model was evaluated using an independent dataset of patients with cutaneous melanoma (n=53). Interactions between trained models and features were rationalised using the explainability method SHAP. Results: The most optimal model was the multi-omic random forest model, with AUC-ROC of 0.78 when predicting response in the independent test dataset. Using SHAP, we predicted thresholds for mutational signatures, neoantigen load, immune cell-type abundance and immune receptor LAG3 expression. The relationship between these influential features and their SHAP scores revealed numerical thresholds constituting good and poor patient response. Conclusions: This approach highlights patient response to ICI is influenced by both cancer intrinsic and extrinsic features, as well as identifies candidate biomarkers that could inform the use of ICI and potentially assist in the selection of combination therapy in melanoma treatment.

6 March 2026 in medRxiv
Verified
Preprint
Open access
PDF file
OKOlga Kondrashova
Olga Kondrashova
RJRebecca L Johnston
Rebecca L Johnston
MPMichael T Parsons
Michael T Parsons
ADAimee L Davidson
Aimee L Davidson
DCDaffodil M Canson
Daffodil M Canson
ASAmanda B Spurdle
Amanda B Spurdle
Accurate classification of BRCA1 and BRCA2 variants is essential for cancer risk assessment and therapy selection, yet over one-third remain variants of uncertain significance (VUS). Here, using 120,660 real-world cancer genomic profiles with BRCA1 or BRCA2 variants from a >800,000-sample cohort, we develop machine learning models that predict pathogenicity using clinical and tumor-derived features, including a pan-cancer homologous recombination deficiency signature, co-mutated genes, zygosity, and cancer type. Trained on classified variants from ClinVar, our models achieved near-perfect performance, with validation ROC-AUC of 1.000 for BRCA1 and 0.989 for BRCA2 variants with ≥5 observations, translating to strong benign or pathogenic evidence for VCEP classification. Applying these models to 1,073 BRCA1 and 1,639 BRCA2 VUS, we strengthened or enabled classification of 39.48% BRCA1 and 50.52% BRCA2 assessable variants. This approach transforms underutilized tumor profiling data into evidence that can be directly integrated into variant classification, providing a scalable framework for other tumor profiling datasets and cancer genes associated with defined tumor genomic features.

30 June 2016 in Journal of Science and Technology Development
Verified
Journal Article
Open access
PDF file
KTKhoa Anh Tran
Khoa Anh Tran
TNTuyet Thi Ngoc Nguyen
Tuyet Thi Ngoc Nguyen
PLPhung Kim Le
Phung Kim Le
The extraction of chili oil and capsaicin from chili using some different method such as Soxhlet, maceration, ultrasound-assisted extraction, microwave-assisted extraction and supercritical carbon dioxide with ethanol as a modifier was studied in this work. The results showed that the main component of chili oil is polyunsaturated fatty acids (representing 77.4%); mainly oleic acid and linoleic acid. The highest yield of oil and capsaicin were 0,5358g/g and 2,9534mg/g material; achieved from microwave-assisted extraction method. However, the highest selectivity was 1.77% with supercritical fluid extraction method. With additional co-solvent, the concentration of capsaicin increased but the selectivity decreased.

23 May 2026 in Scientific Reports
Verified
Journal Article
Open access
KTKhoa A. Tran
Khoa A. Tran
VAVenkateswar Addala
Venkateswar Addala
LKLambros T. Koufariotis
Lambros T. Koufariotis
JZJia Zhang
Jia Zhang
SWScott Wood
Scott Wood
Nic WaddellNic Waddell
Nic Waddell
The identification of reliable predictors for immunotherapy response remains a critical challenge in precision oncology. Here, we integrated patient clinical features with DNA and RNA sequencing data derived from 229 melanoma samples. We use 138 melanoma samples to develop and train machine learning models predicting patient treatment response. Feature selection included a univariate Mann-Whitney U-test screen (p < = 0.05) prior to unique tailoring for each model using SHAP. We identify random forest as the optimal classifier, on an independent cohort of 53 melanoma patients. We test the usefulness of the model using additional test data comprising patients with stable disease (n = 15) and non-cutaneous melanoma (n = 23). Using SHAP, we identified features linked to treatment response including mutation features, immune cell-type abundance and LAG3 expression, highlighting the contributions of both tumour intrinsic and extrinsic factors. Further leveraging SHAP we infer potential numerical thresholds for certain features separating good versus poor immunotherapy response. This explainability driven methodology has potential implications for the clinical translation of biomarker discovery and guiding treatment options to enable precision oncology.